Peripheral Vascular Stents Pipeline Report 2022: Company and Product Overview for 59 Organisations


Dublin, Dec. 14, 2022 (GLOBE NEWSWIRE) -- The "Peripheral Vascular Stents Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update" report has been added to's offering.

The report provides comprehensive information about the Peripheral Vascular Stents pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

A peripheral vascular stent is an expandable perforated tube which is inserted into a peripheral vessel to prevent blood flow constriction. Bare metal stents (BMS), drug eluting stents (DES), covered stents and bio-absorbable stents are covered under this segment. A stent refers to a stent delivery system.


  • Extensive coverage of the Peripheral Vascular Stents under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Peripheral Vascular Stents and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Peripheral Vascular Stents under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Key Topics Covered:

1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Peripheral Vascular Stents Overview

3 Products under Development
3.1 Peripheral Vascular Stents - Pipeline Products by Stage of Development
3.2 Peripheral Vascular Stents - Pipeline Products by Segment
3.3 Peripheral Vascular Stents - Pipeline Products by Territory
3.4 Peripheral Vascular Stents - Pipeline Products by Regulatory Path
3.5 Peripheral Vascular Stents - Pipeline Products by Estimated Approval Date
3.6 Peripheral Vascular Stents - Ongoing Clinical Trials

4 Peripheral Vascular Stents - Pipeline Products under Development by Companies
4.1 Peripheral Vascular Stents Companies - Pipeline Products by Stage of Development
4.2 Peripheral Vascular Stents - Pipeline Products by Stage of Development

5 Peripheral Vascular Stents Companies and Product Overview
5.1 3D Biotek LLC Company Overview
5.2 Abbott Vascular Inc Company Overview
5.3 Acotec Scientific Holdings Ltd Company Overview
5.4 amg International GmbH Company Overview
5.5 AndraTec GmbH Company Overview
5.6 Arterius Ltd Company Overview
5.7 Biotyx Medical (Shenzhen) Co Ltd Company Overview
5.8 Boston Scientific Corp Company Overview
5.9 Cardiatis SA Company Overview
5.10 Cardinal Health Inc Company Overview
5.11 Cook Medical Inc Company Overview
5.12 Cordis Corp Company Overview
5.13 CorInnova, Inc. Company Overview
5.14 Cytograft Tissue Engineering Inc (Inactive) Company Overview
5.15 Efemoral Medical LLC Company Overview
5.16 Efferent Labs Inc Company Overview
5.17 Electroformed Stents Inc Company Overview
5.18 Elixir Medical Corp Company Overview
5.19 FIT Biotech Oy (Inactive) Company Overview
5.20 HeMo Bioengineering Ltd Company Overview
5.21 ID Nest Medical SAS Company Overview
5.22 InspireMD Inc Company Overview
5.23 Kyoto Medical Planning Co Ltd Company Overview
5.24 LeoMed, LLC Company Overview
5.25 Lepu Medical Technology (Beijing) Co Ltd Company Overview
5.26 LimFlow SA Company Overview
5.27 Lyra Therapeutics Inc Company Overview
5.28 Medtronic Inc Company Overview
5.29 Meril Life Sciences Pvt Ltd Company Overview
5.30 Micell Technologies Inc Company Overview
5.31 Micro Medical Solutions Inc Company Overview
5.32 MicroPort Endovascular (Shanghai) Co Ltd Company Overview
5.33 Natec Medical Ltd Company Overview
5.34 Nipro Corp Company Overview
5.35 NSVascular, Inc. Company Overview
5.36 OrbusNeich Company Overview
5.37 PeriTec Biosciences Ltd Company Overview
5.38 QualiMed Innovative Medizinprodukte GmbH Company Overview
5.39 Qvanteq AG Company Overview
5.40 Reflow Medical, Inc. Company Overview
5.41 Shanghai Bio-heart Biological Technology Co Ltd Company Overview
5.42 Shenzhen Salubris Pharmaceuticals Co Ltd Company Overview
5.43 Suzhou Yinluo Medical Devices Co Ltd Company Overview
5.44 Synergy Flow Ltd Company Overview
5.45 Tepha Inc Company Overview
5.46 TissueGen Inc Company Overview
5.47 Tractivus SL Company Overview
5.48 University of Michigan Company Overview
5.49 University of Pittsburgh Company Overview
5.50 University of Pittsburgh Medical Center Company Overview
5.51 Vascular Bioresorbable Technologies Company Overview
5.52 Vascular Concepts Ltd Company Overview
5.53 Vesper Medical Inc Company Overview
5.54 Vinnova Company Overview
5.55 VueKlar Cardiovascular Ltd (Inactive) Company Overview
5.56 Wake Forest University Health Sciences Company Overview
5.57 Xenogenics Corporation Company Overview
5.58 Zorion Medical Company Overview
5.59 Zylox-Tonbridge Medical Technology Co Ltd Company Overview

6 Peripheral Vascular Stents- Recent Developments

7 Appendix

For more information about this report visit


Contact Data